Therapeutic index improvement of antibody-drug conjugates
ABSTRACTThe commentary by Colombo and Rich recently published in Cancer Cell provides a timely and comprehensive review of the clinical maximum tolerated doses (MTDs) of antibody−drug conjugates (ADCs) and their corresponding small molecules/chemotherapies. The authors identified similarities betwee...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Taylor & Francis Group
2023-12-01
|
| Sarja: | mAbs |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2230618 |